Siemens Adds Infectious Disease Tests With Luxembourg's Fast-Track Diagnostics
Executive Summary
Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD) the developer of diagnostics that can distinguish between viral, bacterial, or other infections in one test. The deal comes as Siemens is shaping up to float Healthineers, as an independently publicly-listed company.
You may also be interested in...
M&A Analysis: October Notches 30 Deals In Big M&A Boom
The medtech M&A deal count soared in October with a total of 30 deals announced and closed in the month. It was an especially busy month for the orthopedics sector, with a number of high profile deals inked.
Confirmed: Siemens Aims For H1 2018 IPO for Healthineers
Siemens is planning to spin out its Healthineers business in an IPO slated for the first half of next year, the German conglomerate has confirmed. The move will give the health care business "the required currency and entrepreneurial flexibility" to grow in a fundamentally attractive market, it said. The announcement was made in conjunction with the group's reporting of its third quarter results for fiscal 2017, in which solid diagnostics imaging sales helped to boost the top line for Healthineers.
Biocartis, Fast-track eye 2017 launch of respiratory infection panel for Idylla
Biocartis is partnering with Fast-track diagnostics to develop syndromic multiplex tests that will run on Biocartis’ Idylla analyzer and the first assay is expected to be ready two years from now.